1. Impact of variables on recovery time in patients undergoing hemodialysis: an international survey.
- Author
-
Ozen N, Eyileten T, Teles P, Seloglu B, Gurel A, Ocuk A, Ozen V, Fernandes F, Campos L, Coutinho S, Teixeira J, Moura SCM, Ribeiro O, and Sousa CN
- Subjects
- Humans, Male, Female, Middle Aged, Cross-Sectional Studies, Portugal epidemiology, Adult, Aged, Turkey epidemiology, Time Factors, Fatigue epidemiology, Recovery of Function, Surveys and Questionnaires, Muscle Weakness etiology, Renal Dialysis
- Abstract
Background: Dialysis recovery time (DRT) refers to the period during which fatigue and weakness subside following hemodialysis treatment, allowing patients to resume their daily routines. This study aimed to identify the factors influencing DRT in hemodialysis patients in Turkey and Portugal, where the prevalence of chronic kidney disease is notably high., Methods: A cross-sectional observational study was conducted in a private dialysis center in Turkey and three dialysis centers in Portugal. The study included hemodialysis patients aged 18 years or older who had been undergoing four-hour hemodialysis sessions three times a week for at least six months. Participants had no communication barriers and voluntarily agreed to take part in the study. Data were collected using a semi-structured questionnaire to gather descriptive characteristics and the Hospital Anxiety and Depression Scale. Logistic regression analysis was employed to identify independent variables influencing DRT., Results: A total of 294 patients participated in the study, including 187 from Turkey and 107 from Portugal. In Turkey, increased interdialytic weight gain (P = 0.043) was associated with prolonged recovery time, while the use of high-flux dialyzers (P = 0.026) was linked to shorter recovery times. In Portugal, older age (P = 0.020) was found to extend recovery time., Conclusion: Recovery time after dialysis is influenced by varying factors across different countries. Further research with larger sample sizes is needed to deepen understanding of these factors and their implications., Clinical Trial Number: NCT04667741., Competing Interests: Declarations. Ethics approval and consent to participate: The study was conducted in accordance with the Declaration of Helsinki and was approved by the local ethics committees in Turkey (Kapadokya University Scientific Research and Publication Ethics Committee, permission no: 2020.19, date: July 14, 2020) and Portugal (Escola Superior de Enfermagem do Porto, permission no: 8/2020, date: September 7, 2020). Informed consent was obtained from all subjects and the written permission was obtained from the institutions. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2025
- Full Text
- View/download PDF